��ɫ��

��ɫ��

Donate To Research Join The AAN

Events

Resources For

Abstract Details

Title Modifying Therapies Used in Severe First Idiopathic Acute Inflammatory Events within the Central Nervous System

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 154

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Sara El Alaoui	No disclosure on file
Jean C. Ouallet (Dept of Neurology S258)	Jean C. Ouallet has nothing to disclose.
Patricio Chrem Mendez, MD (FLENI)	Dr. Chrem Mendez has nothing to disclose.
Bruno Brochet, MD, FEAN (University of Bordeaux)	Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for celgene. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for jansen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for novartis. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for merck. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for celgene.
	No disclosure on file